Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Activation of concurrent apoptosis and necroptosis by SMAC mimetics for the treatment of refractory and relapsed ALL
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 8, Issue 339, Pages 339ra70-339ra70
Publisher
American Association for the Advancement of Science (AAAS)
Online
2016-05-19
DOI
10.1126/scitranslmed.aad2986
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- How I treat acute lymphoblastic leukemia in older adolescents and young adults
- (2015) E. Curran et al. BLOOD
- Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
- (2015) Sidi Chen et al. CELL
- Promises and Challenges of Smac Mimetics as Cancer Therapeutics
- (2015) S. Fulda CLINICAL CANCER RESEARCH
- Monitoring minimal residual disease in children with high-risk relapses of acute lymphoblastic leukemia: prognostic relevance of early and late assessment
- (2015) C Eckert et al. LEUKEMIA
- Necroptosis and its role in inflammation
- (2015) Manolis Pasparakis et al. NATURE
- Genomics and drug profiling of fatal TCF3-HLF−positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options
- (2015) Ute Fischer et al. NATURE GENETICS
- The diverse role of RIP kinases in necroptosis and inflammation
- (2015) John Silke et al. NATURE IMMUNOLOGY
- Image-based RNA interference screening reveals an individual dependence of acute lymphoblastic leukemia on stromal cysteine support
- (2015) Jeannette Boutter et al. Oncotarget
- RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
- (2014) Christopher P. Dillon et al. CELL
- Birinapant (TL32711), a Bivalent SMAC Mimetic, Targets TRAF2-Associated cIAPs, Abrogates TNF-Induced NF- B Activation, and Is Active in Patient-Derived Xenograft Models
- (2014) C. A. Benetatos et al. MOLECULAR CANCER THERAPEUTICS
- The Two Faces of Receptor Interacting Protein Kinase-1
- (2014) Ricardo Weinlich et al. MOLECULAR CELL
- Smac mimetics and innate immune stimuli synergize to promote tumor death
- (2014) Shawn T Beug et al. NATURE BIOTECHNOLOGY
- Development and function of human innate immune cells in a humanized mouse model
- (2014) Anthony Rongvaux et al. NATURE BIOTECHNOLOGY
- In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer
- (2014) Ramona Rudalska et al. NATURE MEDICINE
- Small-molecule SMAC mimetics as new cancer therapeutics
- (2014) Longchuan Bai et al. PHARMACOLOGY & THERAPEUTICS
- RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition
- (2014) W. J. Kaiser et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages
- (2014) S. McComb et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hematopoietic RIPK1 deficiency results in bone marrow failure caused by apoptosis and RIPK3-mediated necroptosis
- (2014) Justine E. Roderick et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Control of Life-or-Death Decisions by RIP1 Kinase
- (2013) Dana E Christofferson et al. Annual Review of Physiology
- Toll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
- (2013) William J. Kaiser et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death
- (2013) Dimitry Ofengeim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases
- (2013) R. J. Thapa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Genomic Characterization of Childhood Acute Lymphoblastic Leukemia
- (2013) Charles G. Mullighan SEMINARS IN HEMATOLOGY
- Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
- (2013) T. Pemovska et al. Cancer Discovery
- How I treat relapsed childhood acute lymphoblastic leukemia
- (2012) F. Locatelli et al. BLOOD
- Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening
- (2012) J. W. Tyner et al. CANCER RESEARCH
- Targeting IAP proteins for therapeutic intervention in cancer
- (2012) Simone Fulda et al. NATURE REVIEWS DRUG DISCOVERY
- Xenografts of highly resistant leukemia recapitulate the clonal composition of the leukemogenic compartment
- (2011) M. Schmitz et al. BLOOD
- NEMO and RIP1 Control Cell Fate in Response to Extensive DNA Damage via TNF-α Feedforward Signaling
- (2011) Sharon Biton et al. CELL
- Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse
- (2011) Emmanuelle Clappier et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Cytosolic ATM/NEMO/RIP1 Complex Recruits TAK1 To Mediate the NF- B and p38 Mitogen-Activated Protein Kinase (MAPK)/MAPK-Activated Protein 2 Responses to DNA Damage
- (2011) Y. Yang et al. MOLECULAR AND CELLULAR BIOLOGY
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- Small-molecule pan-IAP antagonists: a patent review
- (2010) John A Flygare et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance
- (2010) Laura Bonapace et al. JOURNAL OF CLINICAL INVESTIGATION
- Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi
- (2010) Johannes Zuber et al. NATURE BIOTECHNOLOGY
- An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer
- (2008) Lars Zender et al. CELL
- Tumor resistance to apoptosis
- (2008) Simone Fulda INTERNATIONAL JOURNAL OF CANCER
- cIAP1 and cIAP2 Facilitate Cancer Cell Survival by Functioning as E3 Ligases that Promote RIP1 Ubiquitination
- (2008) Mathieu J.M. Bertrand et al. MOLECULAR CELL
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
- Both cIAP1 and cIAP2 regulate TNF -mediated NF- B activation
- (2008) D. J. Mahoney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antigen-mediated T cell expansion regulated by parallel pathways of death
- (2008) I. L. Ch'en et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now